Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cutolo, M.
Right arrow Articles by Rodriguez, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cutolo, M.
Right arrow Articles by Rodriguez, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2000; 39: 1366-1373
© 2000 British Society for Rheumatology

Evidence of cerebral hypoperfusion in scleroderma patients

M. Cutolo, F. Nobili1, A. Sulli, C. Pizzorni, M. Briata, F. Faelli, P. Vitali1, G. Mariani2, F. Copello3, B. Seriolo, C. Barone and G. Rodriguez1

Division of Rheumatology
1 Clinical Neurophysiology Service
2 Nuclear Medicine Service, Department of Internal Medicine, University of Genova,
3 Department of Occupational Medicine, S. Martino Hospital, Genova, Italy

Objectives. To investigate regional cerebral blood flow by 99mTc-hexamethylpropylenamineoxime (HMPAO) single photon emission computed tomography (SPECT) in a series of 40 patients (mean age 58.5±11.5 yr) affected by systemic sclerosis (SSc) in comparison with age-matched healthy controls.

Methods. Subjects affected by concomitant severe pathologies that might interfere with the interpretation of the SPECT results were excluded. SPECT findings were correlated with the severity of peripheral microvascular involvement, as assessed by nailfold videocapillaroscopy (NVC). Whenever possible, patients underwent magnetic resonance imaging (MRI) of the brain.

Results. Twenty-one SSc patients (52%) showed hypoperfusion in two or more regions of interest (ROIs) at the SPECT analysis. MRI was available in 14 of these patients, and was shown to be altered in eight of them (57%). One patient with both abnormal SPECT and abnormal MRI was affected by mild cognitive impairment. Transcranial Doppler sonography was normal in all but one of these patients with hypoperfusion. Nineteen patients exhibited a normal brain SPECT scan, but the MRI was shown to be altered in 3/12 of them (25%). No significant differences were found between the group of SSc patients showing hypoperfusion and those showing a normal SPECT scan regarding age, the duration of disease, the presence of vascular risk factors or damage of other organs typically involved in the disease, and the severity of peripheral microvascular involvement (NVC).

Conclusions. Focal or diffuse cerebral hypoperfusion was found in more than half of the neurologically asymptomatic SSc patients studied, paralleling the incidence of altered brain MRI. The hypoperfusion was not linked to ageing and possibly reflects the cerebral location of the microangiopathic process characterizing the disease.

KEY WORDS: Single photon emission computed tomography (SPECT), Magnetic resonance imaging (MRI), Videocapillaroscopy, Systemic sclerosis, Cerebral blood flow.

Correspondence to: M. Cutolo, Division of Rheumatology, Department of Internal Medicine, Viale Benedetto XV No. 6, 16132 Genova, Italy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
M. Cutolo, A. Sulli, M. E. Secchi, S. Paolino, and C. Pizzorni
Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement?
Rheumatology, October 1, 2006; 45(suppl_4): iv43 - iv46.
[Abstract] [Full Text] [PDF]


Home page
JRSMHome page
L. Pinheiro, J. Freitas, M. Lucas, and R. M M Victorino
Cerebellar atrophy in systemic sclerosis
J R Soc Med, November 1, 2004; 97(11): 537 - 538.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. Cutolo, C. Pizzorni, M. Tuccio, A. Burroni, C. Craviotto, M. Basso, B. Seriolo, and A. Sulli
Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis
Rheumatology, June 1, 2004; 43(6): 719 - 726.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
A. Sulli, M. Ghio, G. P. Bezante, L. Deferrari, C. Craviotto, V. Sebastiani, M. Setti, A. Barsotti, M. Cutolo, and F. Indiveri
Blunted coronary flow reserve in systemic sclerosis
Rheumatology, April 1, 2004; 43(4): 505 - 509.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
O Ushiyama, K Ushiyama, T Yamada, S Koarada, Y Tada, N Suzuki, A Ohta, and K Nagasawa
Retinal findings in systemic sclerosis: a comparison with nailfold capillaroscopic patterns
Ann Rheum Dis, March 1, 2003; 62(3): 204 - 207.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.